C12N 2710/16532
Use of virus as therapeutic agent, other than vaccine
Official title: Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
C12N2710/16532 (Use of virus as therapeutic agent, other than vaccine) appears on 3 US grants and 5 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 5
- Assignees
- 5
- Inventors
- 9
- Latest grant
- 3 Apr 2012
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 1 |
| 2010 | 1 | 0 |
| 2011 | 1 | 1 |
| 2012 | 1 | 1 |
By publication year.
Recent patents
- Recombinant viral vector for gene transfer into lymphoid cells3 Apr 2012US 8,148,060 B2The Research Foudation for Microbial Diseases of Osaka University
- Use of herpesviruses, herpesvirus proteins and nucleic acids encoding the proteins to inhibit CCR5-tropic HIV-1 infection and replication28 Jun 2011US 7,968,298 B2The United States of America as represented by the Department of Health and Human Services
- Recombinant viral vector for gene transfer into lymphoid cells26 Oct 2010US 7,820,436 B2The Research Foundation for Microbial Diseases of Osaka University
- Recombinant viral vector for gene transfer into lymphoid cells24 May 2012US 2012/0129263 A1The Research Foundation for Microbial Diseases of Osaka University
- Recombinant viral vector for gene transfer into lymphoid cells24 Mar 2011US 2011/0070651 A1The Research Foudation for Microbial Diseases of Osaka University
- Recombinant Viral Vector for Gene Transfer into Lymphoid Cells8 Oct 2009US 2009/0253208 A1The Research Foundation for Microbial Diseases of Osaka University
- Recombinant virus vector for gene transfer into lymphoid cells18 Sep 2008US 2008/0226677 A1
- Use of herpesviruses, herpesvirus proteins and nucleic acids encoding the proteins to inhibit ccr5-tropic hiv-1 infection and replication9 Jun 2005US 2005/0123510 A1The Government of the United States, as represent- ed by the Secretary of Health and Human Services,
Most cited
By later US patents